2.99
Schlusskurs vom Vortag:
$3.10
Offen:
$3.12
24-Stunden-Volumen:
54,398
Relative Volume:
1.41
Marktkapitalisierung:
$4.90M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-36.46M
KGV:
-1.2458
EPS:
-2.4
Netto-Cashflow:
$-30.20M
1W Leistung:
-11.54%
1M Leistung:
-30.30%
6M Leistung:
+74.85%
1J Leistung:
-26.72%
Alaunos Therapeutics Inc Stock (TCRT) Company Profile
Firmenname
Alaunos Therapeutics Inc
Sektor
Branche
Telefon
(346) 355-4099
Adresse
2617 BISSONNET ST, HOUSTON
Vergleichen Sie TCRT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TCRT
Alaunos Therapeutics Inc
|
2.99 | 5.54M | 0 | -36.46M | -30.20M | -2.40 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2022-10-04 | Fortgesetzt | Wells Fargo | Overweight |
Alaunos Therapeutics Inc Aktie (TCRT) Neueste Nachrichten
Alaunos Therapeutics Announces Departure of Melinda Lackey - TipRanks
Is Alaunos Therapeutics Inc. a good long term investmentBreakthrough profit margins - jammulinksnews.com
Alaunos Therapeutics Inc. Stock Analysis and ForecastFree Stock Selection - jammulinksnews.com
What drives Alaunos Therapeutics Inc. stock priceFree Stock Market Real-Time Monitoring - Autocar Professional
What analysts say about Alaunos Therapeutics Inc. stockRapid wealth creation - Autocar Professional
why alaunos therapeutics inc. stock attracts strong analyst attentionCapital Preservation Investment Ideas - Newser
Alaunos Therapeutics (NASDAQ:TCRT) Shares Up 0.3% – What’s Next? - Defense World
Alaunos Therapeutics appoints Michael A. Jerman to board and audit chair By Investing.com - Investing.com South Africa
Alaunos Therapeutics appoints Michael A. Jerman to board and audit chair - Investing.com
How Alaunos Therapeutics Inc. stock performs during market volatilityFree Exclusive Access to Stock Gurus - Newser
Why Alaunos Therapeutics Inc. stock attracts strong analyst attentionRapid Gain Targets - Newser
What makes Alaunos Therapeutics Inc. stock price move sharplySmart Growth Low Risk Picks - Newser
Alaunos Therapeutics Secures $25M Equity Purchase Deal - MSN
Alaunos Therapeutics Holds Annual Stockholders Meeting - MSN
Alaunos Therapeutics Appoints Holger Weis as New CEO - The Globe and Mail
Alaunos Therapeutics Raises $850,000 in Private Offering - TipRanks
Alaunos Therapeutics Closes Registered Direct Offering - TipRanks
Is Alaunos Therapeutics, Inc. overvalued or undervalued? - MarketsMojo
Alaunos Therapeutics stock slides on $2M equity offering - MSN
Alaunos Therapeutics raises $2 million in registered direct offering - Investing.com
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies - The Manila Times
PMGC Capital Urges Alaunos Therapeutics to Accept Strategic Financing Opportunity - Nasdaq
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) - GlobeNewswire
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading - Bluefield Daily Telegraph
Clean Financing Deal: Top Wall Street Bank Backs Alaunos While Major Investor PMGC Capital Demands Action - Stock Titan
Alaunos Therapeutics Amends Warrant Agreement with Mast Hill - TipRanks
Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Short Interest Update - Defense World
Juvenescence enhances AI drug discovery with Ro5 acquisition - Pharmaceutical Technology
Ziopharm: Q1 Earnings Snapshot - CT Insider
Alaunos Therapeutics (NASDAQ:TCRT) Trading Down 2.4% – Time to Sell? - Defense World
Finanzdaten der Alaunos Therapeutics Inc-Aktie (TCRT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):